2023-05-26T08:23:02+02:00May 26th, 2023|biomarker, biomarkers, microRNAs, NGS|
TAmiRNA Senior Scientist Dr. Kseniya Khamina-Kotisch will present Poster 46 ‘Identification of novel circulating MicroRNA Biomarkers of Central Nervous System Damage by absolute quantitation using a MicroRNA Next-Generation Sequencing Discovery (miND) Assay’. She will also present Poster 66: ‘Comparative characterization and absolute quantitation of small RNAs associated with RNA-induced silencing complexes (RISCs) in cells, plasma, urine, and extracellular vesicles’. Take advantage, meet Kseniya and discuss our latest developments and how TAmiRNA's miND spike ins and services can assist your business!
2023-03-10T10:13:11+01:00October 28th, 2022|microRNA, NGS, smallRNA|
TAmiRNA has launched an innovative NGS technology for absolute quantitation of miRNAs and other small RNAs , the miND® (microRNA Next-Generation Sequencing Discovery) spike-in. The miND® spike-in has been developed for small RNA sequencing experiments and absolute quantitation of microRNAs in any biological matrix and species, overcoming previous challenges of quality control and difficulty in achieving absolute quantitation of miRNAs across different biological matrix and species. click here for more Information on the miND spike-ins
2023-03-10T11:03:50+01:00August 8th, 2018|biomarker, liquid biopsies, microRNAs, osteomiR, thrombomiR|
Click here to read our Technotes